Bone Union Enhancement by bFGF-Containing HAp/Col in Prefabricated Vascularized Allo-Bone Grafts
Background We have developed a prefabricated vascularized allo-bone graft (PVAG) by implanting the saphenous vascular bundles of recipient rats into transplanted donor bones in a flow-through manner. We previously demonstrated that the angiogenetic and bone formative abilities of the PVAG are stimulated by the addition of a basic fibroblast growth factor (bFGF)-containing hydroxyapatite/collagen (HAp/Col). This study aimed to demonstrate that the bone union ability of the PVAG is similarly stimulated by the bFGF-containing HAp/Col composite.
Methods Sprague-Dawley donor rats (n = 32) and Wistar recipient rats (n = 32) were used in this study. The PVAG was fixed to the femur of the recipient rat using K-wire (dimeter: 0.7 mm) pinning, followed by suturing with a 4–0 nylon suture. Recipients were divided into four groups: with or without vascular bundles, and with or without bFGF-containing HAp/Col. Rats were sacrificed 6 weeks after transplantation, and bone union, bone resorption, and angiogenesis were radiologically and histologically evaluated.
Results Radiological analysis revealed a significant increase in callus formation and union rate, while histological analysis showed a significant increase in bone formation and angiogenesis in the group treated with both vascular bundles and bFGF. Bone resorption did not significantly increase in any of the evaluated groups.
Conclusion Osteogenic cells, osteoconductive scaffolds, growth factors, and mechanical environment are known to be important factors in the process of fracture healing. The PVAG developed herein contains osteogenic cells, osteoconductive scaffolds, and growth factors. In addition, the PVAG is rigidly fixed to the fracture site, providing a stable mechanical environment. Together, these four factors contributed to a good bone union. Furthermore, this method did not promote bone resorption. Thus, the addition of a vascular bundle and bFGF-containing HAp/Col makes it possible to create an ideal vascularized allo-bone graft for the reconstruction of massive bone defects.
Received: 08 June 2020
Accepted: 15 August 2020
21 September 2020 (online)
© 2020. Thieme. All rights reserved.
Thieme Medical Publishers
333 Seventh Avenue, New York, NY 10001, USA.
- 1 Goldberg VM, Stevenson S. Natural history of autografts and allografts. Clin Orthop Relat Res 1987; (225) 7-16
- 2 Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 1996; (329) 300-309
- 3 Weiland AJ. Current concepts review: vascularized free bone transplants. J Bone Joint Surg Am 1981; 63 (01) 166-169
- 4 Ceruso M, Falcone C, Innocenti M, Delcroix L, Capanna R, Manfrini M. Skeletal reconstruction with a free vascularized fibula graft associated to bone allograft after resection of malignant bone tumor of limbs. Handchir Mikrochir Plast Chir 2001; 33 (04) 277-282
- 5 Capanna R, Campanacci DA, Belot N. et al. A new reconstructive technique for intercalary defects of long bones: the association of massive allograft with vascularized fibular autograft. Long-term results and comparison with alternative techniques. Orthop Clin North Am 2007; 38 (01) 51-60 , vi
- 6 Doi K, Tominaga S, Shibata T. Bone grafts with microvascular anastomoses of vascular pedicles: an experimental study in dogs. J Bone Joint Surg Am 1977; 59 (06) 809-815
- 7 Vittayakittipong P, Jarudejkajon J, Kirirat P, Chaijaroonkhanarak W, Chaisiwamongkol K. Feasibility of the vascularized fibula bone graft for reconstruction of the mandible: a cadaveric study. Int J Oral Maxillofac Surg 2016; 45 (08) 960-963
- 8 Kaji Y, Nakamura O, Imaizumi Y, Yamamoto T. Attempt to create prefabricated vascularized allogeneic bone graft in the recipient's rat body. Effects of BMP and bisphosphonate on bone formation, promoting bone formation and suppressing bone resorption. J Jpn Soc Reconstr Microsurg 2009; 22: 37-43
- 9 Nakamura O, Kaji Y, Imaizumi Y, Yamagami Y, Yamamoto T. Prefabrication of vascularized bone allograft in a recipient rat using a flow-through vascular pedicle, bone morphogenetic protein, and bisphosphonate. J Reconstr Microsurg 2013; 29 (04) 241-248
- 10 Yamaguchi K, Kaji Y, Nakamura O, Tobiume S, Yamamoto T. Prefabrication of vascularized allogenic bone graft in a rat by implanting a flow-through vascular pedicle and basic fibroblast growth factor containing hydroxyapatite/collagen composite. J Reconstr Microsurg 2017; 33 (05) 367-376
- 11 Radomsky ML, Aufdemorte TB, Swain LD, Fox WC, Spiro RC, Poser JW. Novel formulation of fibroblast growth factor-2 in a hyaluronan gel accelerates fracture healing in nonhuman primates. J Orthop Res 1999; 17 (04) 607-614
- 12 Kawaguchi H, Jingushi S, Izumi T. et al. Local application of recombinant human fibroblast growth factor-2 on bone repair: a dose-escalation prospective trial on patients with osteotomy. J Orthop Res 2007; 25 (04) 480-487
- 13 Kawaguchi H, Oka H, Jingushi S. TESK Group. et al. A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: a randomized, placebo-controlled trial. J Bone Miner Res 2010; 25 (12) 2735-2743
- 14 Tanaka T, Kumagae Y, Chazono M. et al. An injectable complex of beta-tricalcium phosphate granules, hyaluronate, and rhFGF-2 on repair of long-bone fractures with large fragments. Open Biomed Eng J 2014; 8: 52-59
- 15 Kawaguchi H, Nakamura K, Tabata Y. et al. Acceleration of fracture healing in nonhuman primates by fibroblast growth factor-2. J Clin Endocrinol Metab 2001; 86 (02) 875-880
- 16 Jimi E, Shuto T, Ikebe T, Jingushi S, Hirata M, Koga T. Basic fibroblast growth factor inhibits osteoclast-like cell formation. J Cell Physiol 1996; 168 (02) 395-402
- 17 Cao R, Bråkenhielm E, Pawliuk R. et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 2003; 9 (05) 604-613
- 18 Andreopoulos FM, Persaud I. Delivery of basic fibroblast growth factor (bFGF) from photoresponsive hydrogel scaffolds. Biomaterials 2006; 27 (11) 2468-2476
- 19 Cai S, Liu Y, Zheng Shu X, Prestwich GD. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials 2005; 26 (30) 6054-6067
- 20 Freudenberg U, Hermann A, Welzel PB. et al. A star-PEG-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases. Biomaterials 2009; 30 (28) 5049-5060
- 21 Ishii I, Mizuta H, Sei A, Hirose J, Kudo S, Hiraki Y. Healing of full-thickness defects of the articular cartilage in rabbits using fibroblast growth factor-2 and a fibrin sealant. J Bone Joint Surg Br 2007; 89 (05) 693-700
- 22 Zhang H, Wang K, Gao T. et al. Controlled release of bFGF loaded into electrospun core-shell fibrous membranes for use in guided tissue regeneration. Biomed Mater 2020; 15 (03) 035021
- 23 Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature 2003; 423 (6937): 349-355
- 24 Itoh K, Udagawa N, Katagiri T. et al. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology 2001; 142 (08) 3656-3662
- 25 Deckers MM, Van Beek ER, Van Der Pluijm G. et al. Dissociation of angiogenesis and osteoclastogenesis during endochondral bone formation in neonatal mice. J Bone Miner Res 2002; 17 (06) 998-1007
- 26 Giannoudis PV, Einhorn TA, Marsh D. Fracture healing: the diamond concept. Injury 2007; 38 (Suppl. 04) S3-S6